Steve Gelsi
Perella Weinberg Partners said it has raised about $444 million out of a targeted $600 million for PWP Growth Equity Fund I LP about 18 months after it announced the new fund series with two veterans of Weston Presidio.
Stripes Group set a $500 million target for SG Growth Partners III, double the goal of its predecessor fund raised two years ago, in a bullish move for the New York-based growth equity specialist.
Veritas Capital said it quickly wrapped up fundraising for Veritas Capital Fund V LP in one closing with $1.875 billion in commitments, with the New York-based government services specialist drawing solid support from limited partners after the death of its founder in 2012.
Lone Star Funds has closed Lone Star Fund IX LP at its target of $7.4 billion, with the flagship pool for the real estate and distressed debt shop drawing strong support from LPs after a stand-out performance in at least one prior fund and a move to tackle succession issues concerning Chairman John Grayken.
JPMorgan Chase & Co said it has raised $1.05 billion for JPMorgan Digital Growth Fund II, the follow-up to a pool that wrapped up in 2011 and took a stake in Twitter Inc.
Sponsors are making big bets on growth equity this year as a way to avoid pricey LBOs, but analysis of the trend finds there’s no easy way to escape lofty valuations in this emerging area of the dealscape.
Dow Chemical Co is seeing interest from private equity firms in buying its Sodium Borohydride unit, according to sources familiar with the transaction.
Dowling Capital Partners has raised at least $125.4 million for its insurance-focused Dowling Capital Partners II LP fund, less than three years after the Connecticut firm’s inaugural pool.
Centre Partners Management LLC made a 3x return on its nine-year investment in Ross Aviation LLC in the sale of the fixed base operator to Landmark Aviation, a Carlyle Group portfolio company, according to a source familiar with the deal.
With a $774 million debt exchange transaction under its belt, MModal Inc has emerged from Chapter 11 bankruptcy without One Equity Partners, the buyout shop that took the healthcare services firm private in 2012.